Shares of Immunoprecise Antibodies (NASDAQ:IPA), also known as IPA, were up 30% Thursday after its subsidiary BioStrand unveiled an advanced foundation AI model for drug discovery that utilizes large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results